Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-25-000064
Filing Date
2025-08-06
Accepted
2025-08-06 16:22:48
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20250630.htm   iXBRL 10-Q 1448632
2 EX-31.1 anab-6302025x10qxexx311.htm EX-31.1 8342
3 EX-31.2 anab-6302025x10qxexx312.htm EX-31.2 8198
4 EX-32.1 anab-6302025x10qxexx321.htm EX-32.1 4882
5 EX-32.2 anab-6302025x10qxexx322.htm EX-32.2 4779
11 PIPELINE CHART anab-20250630_g1.jpg GRAPHIC 89467
  Complete submission text file 0001370053-25-000064.txt   7906677

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20250630.xsd EX-101.SCH 59266
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20250630_cal.xml EX-101.CAL 55225
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20250630_def.xml EX-101.DEF 237267
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20250630_lab.xml EX-101.LAB 672229
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20250630_pre.xml EX-101.PRE 449606
74 EXTRACTED XBRL INSTANCE DOCUMENT anab-20250630_htm.xml XML 1161051
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 251189996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)